Bronchogen® 20mg (Bioregulator)
CAS: N/A
The Biopeptides Bronchogen® 20mg (Bioregulator) is a high-purity synthetic short-chain peptide formulation developed for advanced laboratory research. Manufactured using Solid-Phase Peptide Synthesis (SPPS) and validated by HPLC, Mass Spectrometry, and UV analysis, it ensures ≥99% purity, molecular accuracy, and batch-to-batch consistency. Widely used by European research institutions, Bronchogen® supports organ-specific cellular signaling, gene expression regulation, and bioregulatory pathway research.
$145.00
Research Use Only
Premium Bioregulatory Research Peptide
Bronchogen® 20mg (Bioregulator) is a laboratory-grade synthetic peptide designed for organ-specific and regulatory pathway research.
It consists of short-chain regulatory peptides studied for their interaction with cellular differentiation, gene expression modulation, and peptide-mediated signaling mechanisms.
Supplied as a high-purity research material, Bronchogen® meets the analytical and documentation standards required by European research institutions.
Scientific Overview
Short-chain bioregulatory peptides are widely studied for their role in fine-tuning cellular communication and gene expression.
Unlike larger biomolecules, these peptides offer predictable degradation profiles and high experimental reproducibility.
Bronchogen® has been investigated in laboratory models related to bronchial and pulmonary tissue signaling pathways.
European research environments value bioregulators for their precision, stability, and suitability for controlled in-vitro experimentation.
Mechanism of Action (Research Context)
- Modulation of organ-specific cellular signaling pathways
- Regulation of gene transcription and expression profiles
- Support of cellular differentiation mechanisms
- Influence on mitochondrial ATP production in regulated models
- Facilitation of enzymatic activation and regulatory peptide signaling
Primary Research Applications
Organ-Specific Signaling Research: Studying regulatory peptide signaling in controlled bronchial and pulmonary tissue models.
Gene Expression Analysis: Investigating transcriptional regulation and peptide-mediated gene modulation.
Bioregulatory Pathway Research: Exploring short-chain peptide control of intracellular regulatory mechanisms.
Protein Expression Studies: Assessing peptide influence on protein synthesis and molecular communication.
Mitochondrial Metabolism Research: Evaluating cellular energy dynamics under peptide-regulated conditions.
Matrix and Cellular Interaction Models: Analyzing peptide effects on cellular structure and extracellular matrix behavior.
Molecular Composition and Characteristics
- Molecular Type: Synthetic bioregulatory peptide complex
- Composition: Short-chain di- and tripeptide sequences
- Structure: Linear peptide chains
- Dose Format: 20mg research vial
- Stability: High when stored under recommended laboratory conditions
Stability Profile and Storage Guidelines
- Supplied as a lyophilized powder for enhanced stability
- Recommended storage temperature: −20°C
- Protect from moisture, humidity, and prolonged light exposure
- Avoid repeated freeze–thaw cycles
- Reconstituted solutions remain stable for approximately 24–48 hours under refrigeration
Solubility and Reconstitution Options
- Bacteriostatic water
- Sterile saline solutions
- Acidic buffer systems
- Compatible organic analytical solvents
Technical Specifications
product Name
Bronchogen® 20mg (Bioregulator)
cas
N/A
purity
≥99% (HPLC verified)
unit Size
20 mg
form
Lyophilized powder
synthesis
Solid-Phase Peptide Synthesis (SPPS)
analytical
HPLC, Mass Spectrometry, UV Spectrophotometry
molecular Structure
Short-chain synthetic peptide complex
stability
High when stored under recommended laboratory conditions
Analytical Validation and Quality Assurance
- HPLC purity and consistency confirmation
- Mass Spectrometry molecular identity verification
- UV spectrophotometric concentration analysis
- Batch-to-batch reproducibility assessment
- Microbial and contamination screening
Regulatory and Compliance Statement
Bronchogen® 20mg (Bioregulator) is supplied strictly for laboratory research and scientific investigation. It is not approved for human consumption, veterinary use, cosmetic applications, or medical treatment. Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS) are available upon request to support EU research compliance.
Frequently Asked Questions
It is used in laboratory research focusing on organ-specific cellular signaling, gene expression regulation, and bioregulatory pathway studies.
Currently, Bronchogen® does not have a registered CAS number, but it is analytically validated for research-grade purity and identity.
Store the lyophilized peptide at −20°C, protected from moisture and light. Avoid repeated freeze–thaw cycles.
No. Bronchogen® 20mg is strictly for laboratory research and is not approved for human or animal use.
Yes. Biopeptides supplies Bronchogen® 20mg to research institutions across Europe with full analytical documentation.
Its short-chain peptide composition allows precise modulation of gene expression and cellular regulatory pathways with high reproducibility.
Purity is confirmed using HPLC, while molecular identity and concentration are verified through Mass Spectrometry and UV analysis.
The 20mg format supports multiple experiments, reduced handling variability, and consistent results across extended research timelines.